RE and Probiotics in MAFLD/NAFLD
RE and Probiotics in MAFLD/NAFLD
Not yet recruiting · NCT06563921 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RE and Probiotics in MAFLD/NAFLD | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Not applicable | 2026-04-09 | NCT06563921 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical University of Warsaw | 89 |
| Nicolaus Copernicus University | 3 |
| University of Oxford | 213 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||